BioSpace News Archive

Alterity Therapeutics today announced that David Stamler, M.D., Chief Executive Officer will participate in the ShareCafe Hidden Gems webinar.

Cytokinetics, Incorporated announced the recipients of its sixth annual Communications Grant Program, intended to support increased capacity in communications, awareness building and community engagement.

Science 37 Holdings, Inc today announced that it has entered into a definitive merger agreement to be acquired by eMed, LLC (“eMed”), the leader in on-demand virtual care and treatment for consumers.

Kiromic BioPharma, Inc. (OTCQB: KRBP) (“Kiromic” or the “Company”) reports favorable early efficacy results from the first patient enrolled in the Phase 1 Deltacel-01 clinical trial with Deltacel ™ for treating stage 4 metastatic non-small cell lung cancer (NSCLC).

Daxor Corporation today announces it will be exhibiting at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Mid-Winter and American College Nuclear Medicine (ACNM) Annual Meeting at the Hilton Orlando Lake Buena Vista in Orlando, FL, February 1-3, 2024.

Autonomix Medical, Inc. announced its common stock will begin trading on the NASDAQ today Monday, January 29, 2024 at approximately 10:30 am EST under the ticker symbol “AMIX.”

4D Molecular Therapeutics today announced that it will host a live webcast to discuss interim data from the intravitreal 4D-150 Phase 2 PRISM clinical trial in wet AMD patients with severe disease activity and high treatment burden, as well as provide a program update on Monday, February 5 at 8:00 a.m. ET.

Palisade Bio, Inc. today announced the presentation of positive preclinical data of its lead asset, PALI-2108 at the Crohn’s & Colitis Congress, which was held on January 25-27, 2024 in Las Vegas, NV.

Adverum Biotechnologies, Inc. today announced that Romuald “Romu” Corbau, Ph.D., has joined Adverum as the company’s chief scientific officer.

IceCure Medical Ltd. today announced the Company is exhibiting and conducting hands-on ProSense® demonstrations at the Society of Interventional Oncology’s (“SIO”) Annual Scientific Meeting which takes place from January 25-29, 2024 in Long Beach, California.